Covington Capital Management - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 26 filers reported holding INMUNE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Covington Capital Management ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2022$6,000
-33.3%
1,0000.0%0.00%
Q2 2022$9,000
+12.5%
1,0000.0%0.00%
Q1 2022$8,000
-20.0%
1,0000.0%0.00%
Q4 2021$10,000
-47.4%
1,0000.0%0.00%
-100.0%
Q3 2021$19,000
+5.6%
1,0000.0%0.00%0.0%
Q2 2021$18,000
+50.0%
1,0000.0%0.00%0.0%
Q1 2021$12,000
-29.4%
1,0000.0%0.00%0.0%
Q4 2020$17,000
+70.0%
1,0000.0%0.00%
Q3 2020$10,000
+100.0%
1,0000.0%0.00%
Q2 2020$5,000
+66.7%
1,0000.0%0.00%
Q1 2020$3,000
-50.0%
1,0000.0%0.00%
Q4 2019$6,0000.0%1,0000.0%0.00%
Q3 2019$6,0001,0000.00%
Other shareholders
INMUNE BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Westside Investment Management, Inc. 37,105$239,7030.07%
QUADRANT CAPITAL GROUP LLC 60,000$387,6000.04%
Janney Montgomery Scott LLC 239,448$1,5470.01%
Financial Advocates Investment Management 11,500$74,2900.01%
MAI Capital Management 19,643$126,8940.00%
VALLEY NATIONAL ADVISERS INC 1,000$80.00%
NORTHERN TRUST CORP 20,297$131,1190.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 9,036$58,3730.00%
GEODE CAPITAL MANAGEMENT, LLC 143,657$928,0240.00%
View complete list of INMUNE BIO INC shareholders